NUCLEAR CYTOPLASMIC RATIO CORRELATES STRONGLY WITH SURVIVAL IN NON-DISSEMINATED NEUROENDOCRINE CARCINOMA OF THE LUNG

被引:19
作者
BATTLEHNER, CN [1 ]
SALDIVA, PHN [1 ]
CARVALHO, CRR [1 ]
TAKAGAKI, TY [1 ]
MONTES, GS [1 ]
YOUNES, RN [1 ]
CAPELOZZI, VL [1 ]
机构
[1] UNIV SAO PAULO,HOSP CLIN,FAC MED,SCH MED,POLUICAO ATMOSFER LAB,AV DR ARNALDO 455,BR-01246 SAO PAULO,BRAZIL
关键词
LUNG; NEUROENDOCRINE TUMORS; STEREOLOGY;
D O I
10.1111/j.1365-2559.1993.tb00065.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In order to verify whether quantitative morphological indices of neuroendocrine carcinoma of the lung may help to predict survival, 47 biopsies (from 37 males and 10 females; 16-82 years of age) were studied by light microscopy. Areal fractions of nuclei, cytoplasm, stroma, and blood vessels were determined using a standard point counting method. The counts were made in six non-coincident microscopic fields in each case, and the areal fractions of nuclei, of the entire tumour cell, stroma, blood vessels and the nuclear/cytoplasmic ratio were computed. In a multivariate linear regression analysis, survival in months after biopsy was considered the dependent variable of age and of all morphometric parameters listed above. The significance level was set at 5%. For all patients (disregarding staging) survival was negatively correlated (P < 0.001, multiple r = 0.5435) with age and nuclear/cytoplasmic ratio. When only patients with disease confined to the thorax (stages I, II and III) were taken into account, the accuracy of the function predicting survival increased considerably (P = 0.004, multiple r = 0.7957). The use of simple stereological methods, therefore, proved to be of value in predicting survival in patients with neuroendocrine carcinomas of the lung.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1982, Am J Clin Pathol, V77, P123
[2]  
BEPLER G, 1989, CANCER, V64, P74, DOI 10.1002/1097-0142(19890701)64:1<74::AID-CNCR2820640113>3.0.CO
[3]  
2-Q
[4]   SURGICAL RESECTION IN THE TREATMENT OF STAGES-I, STAGE-II OF SMALL CELL LUNG-CARCINOMA (SCLC) [J].
CATALDO, I ;
BEDINI, AV ;
MUSCOLINO, G ;
VALENTE, M ;
PASTORINO, U ;
BIDOLI, P ;
PILOTTI, S ;
RAVASI, G .
TUMORI JOURNAL, 1989, 75 (01) :28-30
[5]  
FOX W, 1973, LANCET, V2, P63
[6]  
GOULD VE, 1983, PATHOL ANNU, V18, P287
[7]   SOME NEW, SIMPLE AND EFFICIENT STEREOLOGICAL METHODS AND THEIR USE IN PATHOLOGICAL RESEARCH AND DIAGNOSIS - REVIEW ARTICLE [J].
GUNDERSEN, HJG ;
BENDTSEN, TF ;
KORBO, L ;
MARCUSSEN, N ;
MOLLER, A ;
NIELSEN, K ;
NYENGAARD, JR ;
PAKKENBERG, B ;
SORENSEN, FB ;
VESTERBY, A ;
WEST, MJ .
APMIS, 1988, 96 (05) :379-394
[8]  
HAMMOND ME, 1985, CANCER, V56, P1624, DOI 10.1002/1097-0142(19851001)56:7<1624::AID-CNCR2820560727>3.0.CO
[9]  
2-3
[10]  
HIRSCH FR, 1988, CANCER, V62, P973, DOI 10.1002/1097-0142(19880901)62:5<973::AID-CNCR2820620521>3.0.CO